Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Hull

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|March 13, 1987
Superconductivity at 40 K in the Oxygen-Defect Perovskites La2-xSrxCuO4-yJ M Tarascon, L H Greene, W R McKinnon, et al.
The Canadian Journal of Urology|March 27, 2001
Small cell carcinoma of the prostate: an underrecognized entityS N Nadig, A R Deibler, T M El Salamony, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancerY Nasu, C H Bangma, G W Hull, et al.
Gene Therapy|August 6, 1999
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic modelY Nasu, C H Bangma, G W Hull, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccinesG W Hull, M A Mccurdy, Y Nasu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|March 13, 1987
Superconductivity at 40 K in the Oxygen-Defect Perovskites La2-xSrxCuO4-yJ M Tarascon, L H Greene, W R McKinnon, et al.
The Canadian Journal of Urology|March 27, 2001
Small cell carcinoma of the prostate: an underrecognized entityS N Nadig, A R Deibler, T M El Salamony, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancerY Nasu, C H Bangma, G W Hull, et al.
Gene Therapy|August 6, 1999
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic modelY Nasu, C H Bangma, G W Hull, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccinesG W Hull, M A Mccurdy, Y Nasu, et al.
Pageof 1